Canaccord lowered the firm’s price target on Curaleaf (CURLF) to C$5 from C$6 and keeps a Buy rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CURLF:
- Curaleaf Intl secures regulatory approval for handheld liquid inhalation device
- Curaleaf Holdings’ Mixed Q1: Growth Amid Challenges
- Curaleaf Holdings Reports Q1 2025 Financial Results
- Curaleaf Holdings Reports Q1 2025 Results with Strong International Growth
- Curaleaf reports Q1 adjusted cont ops EPS (7c) vs. (6c) last year